# Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects

> **NCT02322216** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 383 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** Olopatadine Hydrochloride Ophthalmic Solution 0.2%
- **DRUG:** Olopatadine Hydrochloride Ophthalmic Solution 0.1%
- **DRUG:** Olopatadine 0.2% Vehicle

## Key facts

- **NCT ID:** NCT02322216
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 383 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02322216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02322216, "Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02322216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*